Dynamic MapReport

World News   USA   California   Bay Area   North East Bay   Alameda County   Emeryville   Chiron (30)
Emeryville, Chiron Timeline Tuesday, April 24 Bookmark and Share     Author
Search Bay Area News Atlas:
Drug panel divided on Chiron medicine  Chiron is holding out hope that regulators will approve its inhaled medicine to prevent lung transplant rejection Flu shot problem hurts Chiron's profit  1st-quarter results fell well short of analysts' expectations Regulators Lift Suspension on Chiron
World News (12) World Business (847) USA (336) California (187) Bay Area (12) Bay Area Business (1699) North East Bay (1964) Alameda County (451) Emeryville (91) Chiron (30)
2006 (2) 2005 (12) 2004 (8) 2003 (5) 2002 (2) 2001 (1)
Emeryville Chiron on Wikipedia Emeryville Chiron on Web

Emeryville Business (41)   Emeryville Bio Tech (23)   Emeryville Bomb (4)   Emeryville Merger and Acquisition (18)   Fremont Business (63)

Main Event: Big patent win vs. Chiron
on Google Map

B. 2004-10-05 Health Dept. Cancels Flu Shot Clinics SF City Hall
2002-09-07 Big patent win vs. Chiron Genentech

Problems Cause Chiron To Miss Earnings  Chiron Corp. won't ship as many flu shots as it initially had hoped Chiron gets OK on flu shots  FDA had released three lots of Chiron's product Fluvirin Chiron shares head upward  Investors hope that Novartis will boost a $4.5 billion purchase offer that the biotechnology firm turned down $4.5B Offered to Finish Chiron Takeover  Novartis is offering $4.5 billion in cash for the remaining stake in Chiron to complete its takeover Chiron's earnings hit hard  The losses from the back-to-back failures of 2 flu vaccine manufacturing plants eroded profits Chiron Warns on Fewer Flu Vaccines
Chiron shareholders OK sale to Novartis  Shareholders approved a $5.4 billion acquisition by Swiss drug giant Novartis, ending the independent existence Chiron Cleared in SEC Investigation  Regulators have decided not to sanction the company following a probe into the suspension of its flu vaccine license Novartis picks chief to head Chiron uni  Swiss pharmaceutical giant named Dr. Joerg Reinhardt, 49, as the leader of the new division if its $5.1 billion acquisition Novartis to buy Chiron

year 2006 Top ^


year 2005 Top ^

  Chiron's board accepted a $5.1 billion purchase offer from Swiss pharmaceutical giant Novartis AG
  Chiron will not produce as many flu vaccines as previously announced because of production delays

  British regulators are enabling the company to begin reproducing flu drugs
Jan.26 Chiron's 2004 income falls dramatically  Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations

year 2004 Top ^

Oct.20 Flu Vaccine Fiasco Costs Chiron Millions
  Vaccine fiasco will cost the company $91 million Oct.15 Board member quits embattled Chiron  The company announced the resignation of Richard Wills, chief executive of Tektronix, in a one-sentence press release Oct.13   SEC probes Chiron over flu shot shortage  The commission has launched an inquiry into how Chiron handled the disclosure of vaccine-manufacturing problems Oct.5   Health Dept. Cancels Flu Shot Clinics  SF City Hall: The department cancelled its clinics for November, after problems with a Chiron sparked warnings of a vaccine shortage Flu maker Chiron slashes profit outlook
  Chiron cut its profit forecast by more than half after British officials pulled the company's license
Aug.20 Chiron gets temporary restraining order Jul.8 Chiron fined for trading with Cuba Feb.27 Chiron sues animal activists
  Chiron is accusing the activists of waging a violent harassment campaign and supporting the man charged with bombing

year 2003 Top ^

Dec.16 Chiron sells 375,000 additional flu vaccine  U.S. Health Secretary Thompson has announced the purchase from pharmaceutical company Aug.29 FBI opens domestic terrorism probe Aug.28 2 small blasts near Chiron offices
  No injuries were reported in the blasts, which hit around 3 a.m. and 4 a.m. Chiron makes vaccines and drugs
May.19 Chiron to buy vaccine maker PowderJect
  Chiron will buy British rival for about $878 million
Mar.20 Chiron names new chief executive  Biotechnology company appointed former GlaxoSmithKline Plc executive Howard Pien its new CEO and president

year 2002 Top ^

Sep.7 Big patent win vs. Chiron
  Genentech: Chiron of Emeryville has no claim to any profits from Genentech's blockbuster breast cancer drug, Herceptin Jan.8   Chiron to buy Matrix
  Fremont: Emeryville's Chiron would buy biotech firm Matrix Pharmaceuticals for $61 million in cash

year 2001 Top ^

Mar.12   Chiron has good year
  Since the beginning of 2001, biotech stock down 16 percent, but Chiron is ahead 1 percent

Add a favorite (file a bookmark) to Emeryville, Chiron Timeline

Please send feedback to: support@mapreport.com

Advertise on Emeryville, Chiron Page

Neighbor Real Estate: